Jillian Michaels is not a fan of the latest weight loss trend — celebs and millions of non-celebs using diabetes meds to slim down — and she says actual data proves it’s just not worth the risk.
The fitness guru joined “TMZ Live” Wednesday and shared concerns about the diabetes drug Semaglutide — sold as brands like Wegovy and Ozempic — which got FDA approval in 2021 for “chronic weight management” in adults with weight-related health conditions.
Jillian tells us the injectable drug has significant side effects ranging from typical to severe … including thyroid cancer, kidney issues and pancreatitis.
Set aside, for just a moment, the fact the diet craze — which folks like Chelsea Handler, Elon Musk and Michael Rubin have copped to joining — is making it harder for diabetes patients to fill potentially lifesaving prescriptions.
But, JM says the drugs don’t actually help folks achieve significant weight loss goals. She adds, the real kicker is one study shows some users regained nearly 70% of the weight they’d lost by taking the drug.
Ultimately, Jillian says you can reach achieve much more effective, long-lasting weight loss by getting active and making better dietary choices.
She acknowledges some people just want shortcuts, and says everyone can make individual choices — but when you see the data it’s clear, at least to Jillian, the risks outweigh the potential short-term benefits.
Image & Source Credit: tmz.com